Search
The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.
The New York-based company will use the funds to expand its in-person and online therapy platform.
The plans are committing to adopt value-driven payment structures that expand tech-enabled care for Medicare beneficiaries with chronic conditions.
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
The partnership allows Sleep Cycle users to access Dreem Health’s network of sleep specialists for evaluation and treatment of sleep disorders directly through the app.
The company will use the funds to develop AI capabilities and move into weight loss, cardiometabolic care, diabetes, thyroid disorders and cardiovascular disease.
The expansion will result in Protera Health bringing its virtual musculoskeletal care model to the Emplify health employee population.
The company gives patients with chronic diseases access to tools that help them monitor their heart rate and blood pressure.
Members, including couples and teens 13 and above, will have access to Talkspace, while members aged 18 and older can receive support with psychiatric medications.
The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.
